迈普医学(301033.SZ)：可吸收再生氧化纤维素止血颗粒进入临床试验阶段

Core Viewpoint - The company, Maipu Medical (301033.SZ), has announced that its research project "Absorbable Regenerative Oxidized Cellulose Hemostatic Granules" has officially entered the clinical trial phase [1] Group 1 - The product is designed to be used as an auxiliary hemostatic agent in surgical procedures when traditional methods such as ligation are ineffective or cannot be performed [1] - It aims to control bleeding from capillaries, veins, and small arteries [1]